medigraphic.com
ISSN 1029-3035 (Electronic)

2015, Number 4

<< Back Next >>

Mediciego 2015; 21 (4)

Diabetes mellitus and chronic kidney disease in the elderly. A necessary revision

González RR, González RR, Barcón DL

Language: Spanish
References: 33
Page: 74-80
PDF size: 75.80 Kb.


ABSTRACT

Introduction: aging brings damaging consequences in renal function and alterations in the metabolism of carbohydrates. Chronic kidney disease is a common complication of diabetes mellitus; this is the main cause that requires renal replacement therapy. Actually the high life expectancy, and the high incidence of diabetes mellitus, leads to an increase in diabetes-related chronic kidney disease in the elderly.
Objective: to carried out a review on diabetes mellitus and chronic kidney disease in the elderly, with emphasis on fundamental characteristics of news on the subject.
Method: a comprehensive literature search was carried out, which were no restrictions on the type of study. Abstracts were reviewed and, where necessary the full articles; all items included recommendations on diabetes mellitus and chronic kidney disease in the elderly were taken into account.
Conclusions: the review showed that diabetes mellitus and chronic kidney disease are the major diseases in the elderly, which are accompanied by organic and functional alterations of age.


REFERENCES

  1. Camero Machín JC, Curbelo Fajardo JC, Martínez Núñez M, Novales Amado A, Trasancos Delgado M. Efectividad de una intervención educativa en adultos mayores diabéticos: Policlínico "Raúl Sánchez", Pinar del Río 2007. Rev Ciencias Médicas [Internet]. 2008 [citado 17 Ago 2010];12(2):99-109. Disponibe en: http://scielo.sld.cu/scielo.php?pid=S1561- 31942008000200012&script=sci_arttext

  2. Vega Restrepo T. Evaluación funcional de los ancianos. II Parte. Rev Geriát. 2013;12(2):31-4.

  3. Trasancos Delgado M, Casanova Moreno M de la C, González Corrales S, Novales Amado A, Baños Hernández I. Factores de riesgo vascular en ancianos diabéticos tipo 2. Rev Ciencias Méd [Internet]. 2010 [Citado 14 Oct 2011];15(2):34-44. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-31942011000200004&script=sci_arttext

  4. Dot Pérez LC, Díaz Calzada M, Pérez Labrador J, Torres Marín JC, Díaz Valdés M. Características clínico, epidemiológicas de la diabetes mellitus en el adulto mayor. Rev Ciencias Méd [Internet]. 2011 [citado 23 Nov 2011];15(2):157-69. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-1942011000200015&script=sci_arttext&tlng=es

  5. Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L. Chronic kidney disease and diabetes. Maturitas. 2012;71:94-103.

  6. Reutens AT. Epidemiology of diabetic kidney disease. Med Clin North Am. 2013;97:1-18.

  7. Sicree R, Shaw JE, Zimmet PZ. The global burden of diabetes En: Gan D, editor. Diabetes Atlas. 2da ed. Brussels: International Diabetes Federation; 2003. p. 15-71.

  8. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379:165-80.

  9. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650-64.

  10. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36:11-66.

  11. Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol. 2011;119(1):1-5.

  12. Goldfarb-Rumyantzev AS, Rout P. Characteristics of elderly patients with diabetes and endstage renal disease. Semin Dial. 2010;23:185-90.

  13. Sánchez Mojarrieta M, Jerez Fernández E. Estrés oxidativo y radicales libres. ¿Amigos o enemigos? 1ra ed. Pinar del Río: Ediciones Loynaz; 2012.

  14. Alarcón Chambi MI, Aguilar Huarita RW, Alejo Soliz CM, Gutiérrez Méndez JE. Factores de riesgo asociados a Nefropatía Diabética en pacientes ingresados a hemodiálisis del Hospital Viedma desde enero de 2006 hasta enero de 2012. Rev Cient Cienc Méd. 2012;15(2):12-7.

  15. Keane WF, Lyle PA. Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study. Am J Kidney Dis. 2003;41(1):22-5.

  16. Hernández Rodríguez A, Rodríguez Constantín A, Rodríguez Beyris R. Enfermedad renal oculta en pacientes con diabetes mellitus. MEDISAN [Internet]. 2011 [citado 23 Feb 2015];15(3):293-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011000300004&lang=pt

  17. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.

  18. Rodríguez Constantín A, Rodríguez Beyrís RP. Insuficiencia renal crónica en pacientes con diabetes mellitus de tipo 2 en un área de salud. MEDISAN [Internet]. 2009 [citado 23 Feb 2015];13(6):[aprox. 12 p.]. Disponible en: http://bvs.sld.cu/revistas/san/vol13_6_09/san08609.htm

  19. Alcázar R, Egocheaga MI, Orte L, Lobos JM, González Parra E, Álvarez Guisasola F, et al. Documento de consenso SEN-SEMFYC sobre enfermedad renal crónica. Rev Nefrología. 2008;28:273-82.

  20. Garg R, Williams ME. Diabetes management in the kidney patient. Med Clin North Am. 2013;97:135-56.

  21. Aires Neto P, Gomes HV, Campos M. Management of hyperglycemia in patients with chronic kidney disease. J Nephrol. 2013;26:629-35.

  22. Almalki MH, Altuwaijri MA, Almehthel MS, Sirrs SM, Singh RS. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials. Clin Invest Med. 2012;35:132-43.

  23. Paniagua R, Ventura MD, Ávila-Díaz M, Cisneros A, Vicente Martínez M, Furlong MD, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422-32.

  24. Abe M, Okada K, Soma M. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice. Curr Drug Metab. 2011;12:57-69.

  25. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012;60:850-86.

  26. Garg R, Williams ME. Diabetes management in the kidney patient. Med Clin North Am. 2013;97:135-56.

  27. Aires Neto P, Gomes HV, Campos M. Management of hyperglycemia in patients with chronic kidney disease. J Nephrol. 2013;26:629-35.

  28. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Trevisan R, et al. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc. 2013;61:1253-61.

  29. Hasslacher C, Multinational Repaglinide Renal Study Group. Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. Diabetes Care. 2003;26:886-91.

  30. Bourdel Marchasson I, Schweizer A, Dejager S. Incretin therapies in the management of elderly patients with type 2 diabetes mellitus. Hosp Pract. 2011;39:7-21.

  31. Grunberger G. Clinical utility of the dipeptidyl peptidase 4 inhibitor linagliptin. Postgrad Med. 2013;3:79-90.

  32. Scheen AJ. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes Obes Metab. 2010;8:648-58.

  33. Schweizer A, Dejager S. Experience with vildagliptin in patients >75 years with type 2 diabetes and moderate or severe renal impairment. Diabetes Ther. 2013;4:257-67.




2020     |     www.medigraphic.com